Get notified when VRDN files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: VRDN Viridian Therapeutics, Inc.\DE 8-K

Viridian eliminates all debt with $55.1M prepayment to Hercules Capital

Filed May 28, 2026 · Period ending May 27, 2026 · ~1 min read

Key Changes

  • high

    Viridian paid $55.1M on May 27 to fully terminate its Hercules Capital loan facility, eliminating all debt obligations, covenants, and future interest payments. The company is now debt-free.

    Item 1.01 view on EDGAR →
  • medium

    The terminated loan carried a high interest rate of 8.95-9.45% annually on $50M borrowed from a $300M facility, representing significant financing costs now avoided.

    Item 1.01 view on EDGAR →
  • medium

    The prepayment eliminates interest-only payments through 2029-2030 and subsequent principal payments until the October 2030 maturity date, improving cash flow predictability.

    Item 1.01 view on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.

Partner

Trade VRDN commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · May 28, 2026 · How we verify